PATENT CLAIM ANALYSIS

Application Number: 16054578
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-11
Patent Classification: ["514", "166000"]

Abstract:
The presently described technology provides compositions comprising aryl carboxylic acids and, for example NSAIDs, chemically conjugated to oxymorphone (4,5-α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one) to form novel prodrugs/compositions of oxymorphone, including benzoates, salicylates, propionates, fenamates, and acetates, which have a decreased potential for abuse of oxymorphone. The present technology also provides methods of treating patients, pharmaceutical kits and methods of synthesizing conjugates of the present technology.

Claim (Index 23):
The composition of  claim 22 , wherein the binder is selected from the group consisting of hydroxypropylmethylcellulose, ethyl cellulose, povidone, acrylic and methacrylic acid co-polymers, pharmaceutical glaze, gums, and milk derivatives.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 96.0
- Lexical Diversity: 1.5102
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15589158', '14956642', '14952348', '15812730', '15376211']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.876705364365459
- 35 USC 102 Novelty (BERT): 0.7036970660713293
- Combined Prediction Score: 0.859404534536046
- Mean Citation Score: 713.681838
- Max Citation Score: 842.2819999999997
- Similarity Product: 713.302006155729

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test